At a glance
- Originator Whitby Pharmaceuticals
- Class Heart failure therapies; Peripheral vasodilators
- Mechanism of Action Adenosine A1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bradycardia; Heart arrest; Heart failure
Most Recent Events
- 24 Mar 1997 No-Development-Reported for Bradycardia in USA (PO)
- 24 Mar 1997 No-Development-Reported for Heart arrest in USA (PO)
- 24 Mar 1997 No-Development-Reported for Heart failure in USA (PO)